22nd Century Group Stock (NASDAQ:XXII)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.19

52W Range

$0.15 - $11.20

50D Avg

$0.43

200D Avg

$1.49

Market Cap

$4.98M

Avg Vol (3M)

$3.89M

Beta

1.39

Div Yield

-

XXII Company Profile


22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Show More

Industry

Tobacco

Sector

Consumer Defensive

Exchange

NASDAQ

ADR

-

Country

US

Employees

64

IPO Date

Jan 26, 2011

Website

XXII Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22
Tobacco$40.50M

Fiscal year ends in Dec 23 | Currency in USD

XXII Financial Summary


Dec 23Dec 22Dec 21
Revenue$32.20M$62.11M$30.95M
Operating Income$-44.93M$-57.11M$-28.33M
Net Income$-140.78M$-59.80M$-32.61M
EBITDA$-43.42M$-59.51M$-24.22M
Basic EPS$-6.80$-4.65$-3.13
Diluted EPS$-6.80$-4.65$-3.13

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 13, 24 | 10:10 AM
Q1 24May 15, 24 | 12:00 AM
Q4 23Mar 28, 24 | 10:05 AM

Peer Comparison


TickerCompany
GNLNGreenlane Holdings, Inc.
HPCOHempacco Co., Inc.
TPBTurning Point Brands, Inc.
VGRVector Group Ltd.
PMPhilip Morris International Inc.
KAVLKaival Brands Innovations Group, Inc.
UVVUniversal Corporation
RLXRLX Technology Inc.